Showing results (61-70 of 131) with videos related to

Sort By:
Pageof 14
Experientia|February 15, 1994
Bovine microvascular endothelial cells of separate morphology differ in growth and response to the action of interferon-gammaA M Fenyves, M Saxer, K Spanel-Borowski
Methods of Information in Medicine|September 12, 2006
Standardized documentation of drug recommendations in discharge letters--a contribution to quality management in cooperative careP Knaup, J Pilz, J Kaltschmidt, et al.
British Journal of Clinical Pharmacology|December 22, 1999
Auditory and electroencephalographic effects of midazolam and alpha-hydroxy-midazolam in healthy subjectsM A Hotz, R Ritz, L Linder, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 9, 2004
Voriconazole-induced QT interval prolongation and ventricular tachycardia: a non-concentration-dependent adverse effectY Alkan, W E Haefeli, J Burhenne, et al.
European Journal of Clinical Investigation|December 3, 1999
Methylenetetrahydrofolate reductase polymorphism, plasma homocysteine and ageL Todesco, C Angst, P Litynski, et al.
Clinical Pharmacology and Therapeutics|October 1, 1996
Substance P in human hand veins in vivo: tolerance, efficacy, potency, and mechanism of venodilator actionW M Strobel, T F Lüscher, D Simper, et al.
Pharmacogenetics|January 26, 1999
Acetaminophen is an inhibitor of hepatic N-acetyltransferase 2 in vitro and in vivoJ P Rothen, W E Haefeli, U A Meyer, et al.
Der Internist|February 4, 2010
[Drug interactions]V Hafner, B Grün, C Markert, et al.
Zeitschrift Fur Gerontologie Und Geriatrie|July 27, 2019
[Epidemiology and prevention of heat-related adverse health effects on elderly people]A Herrmann, W E Haefeli, U Lindemann, et al.
Clinical Pharmacology and Therapeutics|March 21, 2013
A nanogram dose of the CYP3A probe substrate midazolam to evaluate drug interactionsB Halama, N Hohmann, J Burhenne, et al.
Pageof 14